Literature DB >> 10446083

Urinary albumin excretion. An independent predictor of ischemic heart disease.

K Borch-Johnsen1, B Feldt-Rasmussen, S Strandgaard, M Schroll, J S Jensen.   

Abstract

Cross-sectional studies suggest that an increased urinary albumin excretion rate is associated with cardiovascular disease, dyslipidemia, and hypertension. The purpose of this study was to analyze prospectively whether the urinary albumin-to -creatinine (A/C) ratio can independently predict ischemic heart disease (IHD) in a population-based cohort. In 1983, urinary albumin and creatinine levels were measured, along with the conventional atherosclerotic risk factors, in 2085 consecutive participants without IHD, renal disease, urinary tract infection, or diabetes mellitus. The participants were followed up until death, emigration, or December 31, 1993. IHD was defined as a hospital discharge diagnosis or cause of death including the diagnoses ICD-8 and 410 to 414. Seventy-nine individuals developed IHD during the 21 130 person-years of follow-up. They were characterized by a preponderance of males and higher age, body mass index, blood pressure, lipoproteins, and proportion of current smokers. Microalbuminuria was defined as an A/C ratio) >90 percentile (>0.65 mg/mmol). When adjusted for other risk factors, the relative risk of IHD associated with microalbuminuria was 2.3 (95% CI, 1.3 to 3.9, P=0.002), and the 10-year disease-free survival decreased from 97% to 91% (P<0.0001) when microalbuminuria was present. An interaction between microalbuminuria and smoking was observed, and the presence of microalbuminuria more than doubled the predictive effect of the conventional atherosclerotic risk factors for development of IHD. It is concluded that microalbuminuria is not only an independent predictor of IHD but also substantially increases the risk associated with other established risk factors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10446083     DOI: 10.1161/01.atv.19.8.1992

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  59 in total

Review 1.  Are angiotensin converting enzyme inhibitors and angiotensin receptor blockers becoming the treatment of choice in African-Americans?

Authors:  Andrew Fenves; C Venkata S Ram
Journal:  Curr Hypertens Rep       Date:  2002-08       Impact factor: 5.369

2.  Estimating laboratory precision of urinary albumin excretion and other urinary measures in the International Study on Macronutrients and Blood Pressure.

Authors:  Alan R Dyer; Philip Greenland; Paul Elliott; Martha L Daviglus; George Claeys; Hugo Kesteloot; Queenie Chan; Hirotsugu Ueshima; Jeremiah Stamler
Journal:  Am J Epidemiol       Date:  2004-08-01       Impact factor: 4.897

Review 3.  Microalbuminuria and C-reactive protein: similar messengers of cardiovascular risk?

Authors:  Stephan J L Bakker; Ron T Gansevoort; Erik M Stuveling; Rijk O B Gans; Dick de Zeeuw
Journal:  Curr Hypertens Rep       Date:  2005-10       Impact factor: 5.369

4.  Clinical characteristics, cardiac events and coronary angiographic findings in the prospective PREVEND cohort: an observational study.

Authors:  C A Geluk; R A Tio; J G P Tijssen; R B van Dijk; W A Dijk; H L Hillege; P E de Jong; W H van Gilst; F Zijlstra
Journal:  Neth Heart J       Date:  2007       Impact factor: 2.380

5.  Clinical trials report. Chronic kidney disease: blood pressure, treatment goals, and cardiovascular outcomes.

Authors:  Matthew R Weir
Journal:  Curr Hypertens Rep       Date:  2003-10       Impact factor: 5.369

6.  Proteinuria and metabolic syndrome as predictors of cardiovascular death in non-diabetic and type 2 diabetic men and women.

Authors:  A Juutilainen; S Lehto; T Rönnemaa; K Pyörälä; M Laakso
Journal:  Diabetologia       Date:  2005-12-20       Impact factor: 10.122

7.  Usefulness of the renal resistive index to predict an increase in urinary albumin excretion in patients with essential hypertension.

Authors:  K Miyoshi; T Okura; A Tanino; M Kukida; T Nagao; J Higaki
Journal:  J Hum Hypertens       Date:  2016-06-09       Impact factor: 3.012

Review 8.  Appropriate drug therapy for improving outcomes in diabetic nephropathy.

Authors:  Robert D Toto
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

9.  Helicobacter pylori seropositivity in diabetic patients is associated with microalbuminuria.

Authors:  Goh Eun Chung; Nam Ju Heo; Min Jung Park; Su Jin Chung; Hae Yeon Kang; Seung Joo Kang
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

10.  Albuminuria and peripheral arterial disease: results from the multi-ethnic study of atherosclerosis (MESA).

Authors:  K Wattanakit; A R Folsom; M H Criqui; H J Kramer; M Cushman; S Shea; A T Hirsch
Journal:  Atherosclerosis       Date:  2008-02-20       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.